Replies to post #61 on Wright Medical Group, Inc. CVR (WMGIZ)

[fredman]

The FDA will likely require further action from the company on at least one or more issues in the form 483 response, resulting in further delay of Augment approval. Odds are WMGIZ will head lower, all imo.

Bob Palmisano - President and CEO

"The inspection that occurred at the vendor had 13 observations."

Source: http://seekingalpha.com/article/2951646-wright-medical-groups-wmgi-ceo-robert-palmisano-on-q4-2014-results-earnings-call-transcript?part=single